Insider trade

Inhibrx Biosciences (INBX)Director bought ~$496K

Jon Faiz Kayyem, Director at Inhibrx Biosciences, bought ~$496K of Inhibrx Biosciences shares.

~$496K
Approx. value · 35K sh @ $14.23: 51K
Holds after · shares reported

Traded: Nov 19, 2024
Filed: Nov 22, 2024

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

Oct 3, 2024InsiderDirector purchased ~$100K of INBX shares in the open market
Nov 19, 2024 · this disclosureInsiderDirector purchased ~$496K of INBX shares in the open market

What came next

Nov 19, 2024InsiderDirector purchased ~$496K of INBX shares in the open market
Nov 20, 2024Insider · 1 personInsiders: 2 purchases (~$532K)

View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Inhibrx Biosciences

For Inhibrx Biosciences, OQRO holds 5 insider filings (SEC Form 4 or Form 144) and 2 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its INBX page.

Other recent filings by Jon Faiz Kayyem, Director

The full history of Jon Faiz Kayyem, Director is on the profile page.

How this filing works

Other disclosures at Inhibrx Biosciences

Everything OQRO holds on this company is on its INBX page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO Pro Already have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data